AU597924B2 - Solubilization of protein aggregates - Google Patents

Solubilization of protein aggregates Download PDF

Info

Publication number
AU597924B2
AU597924B2 AU66874/86A AU6687486A AU597924B2 AU 597924 B2 AU597924 B2 AU 597924B2 AU 66874/86 A AU66874/86 A AU 66874/86A AU 6687486 A AU6687486 A AU 6687486A AU 597924 B2 AU597924 B2 AU 597924B2
Authority
AU
Australia
Prior art keywords
protein
cationic surfactant
cations
insoluble
source
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU66874/86A
Other languages
English (en)
Other versions
AU6687486A (en
Inventor
Malcolm Roy Brandon
Joseph John Patroni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NATINCO NV
Original Assignee
Bunge Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bunge Australia Pty Ltd filed Critical Bunge Australia Pty Ltd
Priority to AU66874/86A priority Critical patent/AU597924B2/en
Publication of AU6687486A publication Critical patent/AU6687486A/en
Application granted granted Critical
Publication of AU597924B2 publication Critical patent/AU597924B2/en
Assigned to FIDELITY FOOD TECHNOLOGIES PTY. LTD. reassignment FIDELITY FOOD TECHNOLOGIES PTY. LTD. Alteration of Name(s) in Register under S187 Assignors: BUNGE (AUSTRALIA) PTY LTD
Assigned to SOUTHERN CROSS BIOTECH PTY LTD. reassignment SOUTHERN CROSS BIOTECH PTY LTD. Alteration of Name(s) in Register under S187 Assignors: FIDELITY FOOD TECHNOLOGIES PTY. LTD.
Assigned to NATINCO NV reassignment NATINCO NV Alteration of Name(s) in Register under S187 Assignors: SOUTHERN CROSS BIOTECH PTY LTD.
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU66874/86A 1985-12-11 1985-12-11 Solubilization of protein aggregates Expired AU597924B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU66874/86A AU597924B2 (en) 1985-12-11 1985-12-11 Solubilization of protein aggregates

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPH3818 1985-12-11
AUPH381885 1985-12-11
AU66874/86A AU597924B2 (en) 1985-12-11 1985-12-11 Solubilization of protein aggregates

Publications (2)

Publication Number Publication Date
AU6687486A AU6687486A (en) 1987-06-18
AU597924B2 true AU597924B2 (en) 1990-06-14

Family

ID=3771404

Family Applications (1)

Application Number Title Priority Date Filing Date
AU66874/86A Expired AU597924B2 (en) 1985-12-11 1985-12-11 Solubilization of protein aggregates

Country Status (14)

Country Link
US (1) US4797474A (OSRAM)
EP (1) EP0226448B1 (OSRAM)
JP (1) JPH0660198B2 (OSRAM)
CN (1) CN86108729A (OSRAM)
AT (1) ATE76878T1 (OSRAM)
AU (1) AU597924B2 (OSRAM)
CA (1) CA1281849C (OSRAM)
DE (1) DE3685562T2 (OSRAM)
DK (1) DK171331B1 (OSRAM)
ES (1) ES2032194T3 (OSRAM)
GR (1) GR3004903T3 (OSRAM)
MY (1) MY101204A (OSRAM)
NO (1) NO864990L (OSRAM)
NZ (1) NZ218586A (OSRAM)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5037644A (en) * 1986-10-27 1991-08-06 Cetus Corporation Pharmaceutical compositions of recombinant interleukin-2 and formulation processes
AU612133B2 (en) * 1987-02-20 1991-07-04 Natinco Nv Production of proteins in active forms
CA1305285C (en) * 1987-04-21 1992-07-14 Malcolm Roy Brandon Production of proteins in active forms
US4931543A (en) * 1987-05-11 1990-06-05 Cetus Corporation Process for recovering microbially produced interleukin-2
US5654176A (en) * 1987-05-28 1997-08-05 Amrad Corporation Limited Fusion proteins containing glutathione-s-transferase
AU609824B2 (en) * 1987-06-15 1991-05-09 Southern Cross Biotech Pty Ltd. Production of proteins in active forms
EP0295859B1 (en) * 1987-06-15 1994-11-17 Southern Cross Biotech Pty.Ltd. Production of proteins in active forms
US5266205A (en) * 1988-02-04 1993-11-30 Battelle Memorial Institute Supercritical fluid reverse micelle separation
US5637566A (en) * 1988-08-24 1997-06-10 Southern Cross Biotech Pty. Ltd. Method of improving carcass quality by administering growth hormone
US5136027A (en) * 1989-05-02 1992-08-04 Abbott Laboratories Method for renaturing proteins in the presence of alkyl sulfate detergents
DE69122280T2 (de) * 1990-03-01 1997-04-24 Hewlett Packard Co Minimierung von Eluatbandbreiten in der Flüssigchromatographie
US5530100A (en) * 1990-05-07 1996-06-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Methods for purification of recombinantly produced proteins
EP0529201B1 (en) * 1991-08-26 1997-09-24 Hewlett-Packard Company Chromatographic method with micellar on-column enrichment
US5252216A (en) * 1992-03-24 1993-10-12 Smithkline Beecham Corporation Protein purification
US6281212B1 (en) 1996-07-12 2001-08-28 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
ZA9711733B (en) 1996-12-31 1998-07-01 Monsanto Co Method for solubilization and naturation of somatotropins
US20020052026A1 (en) 1997-10-08 2002-05-02 Steven M. Vicik Methods of refolding proteins
EP2158923B1 (en) 1998-08-06 2013-02-27 Mountain View Pharmaceuticals, Inc. Peg-urate oxidase conjugates and use thereof
US7319021B2 (en) * 2002-11-01 2008-01-15 Promega Corporation Cell lysis composition, methods of use, apparatus and kit
DE10309691B4 (de) 2003-02-28 2018-10-04 Hans-Knöll-Institut für Naturstoff-Forschung e.V. Gewinnung von löslichen Proteinen aus der Biomasse rekombinanter Mikroorganismen
TWI418564B (zh) * 2005-04-11 2013-12-11 Savient Pharmaceuticals Inc 利用陽離子界面活性劑之蛋白質純化
US8148123B2 (en) 2005-04-11 2012-04-03 Savient Pharmaceuticals, Inc. Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
DK3321359T3 (da) 2005-04-11 2021-03-08 Horizon Pharma Rheumatology Llc Variante former af uratoxidase og anvendelse deraf
CN102807973A (zh) 2005-04-11 2012-12-05 萨文特医药公司 尿酸氧化酶的变体形式及其用途
US20080159976A1 (en) * 2005-04-11 2008-07-03 Jacob Hartman Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
WO2008051178A2 (en) 2006-04-12 2008-05-02 Savient Pharmaceuticals, Inc. Purification of proteins with cationic surfactant
JP2008545665A (ja) * 2005-05-23 2008-12-18 ユニベルシテ ドゥ ジュネーブ 高体温による処置のための注入可能な超常磁性ナノ粒子および高体温インプラントを形成するための使用
AU2006325982B2 (en) * 2005-12-14 2011-11-24 Denka Company Limited Immunochromatography detection of multidrug-resistant Staphylococcus and diagnostic kit
WO2008034016A2 (en) * 2006-09-15 2008-03-20 Foldrx Pharmaceuticals, Inc. Assays for detecting native-state proteins and identifying compounds that modulate the stability of native-state proteins
US9706787B2 (en) * 2007-10-05 2017-07-18 Advance International Inc. Systems and methods for deriving protein powder
US8663725B2 (en) * 2007-10-05 2014-03-04 Advance International Inc. Method for deriving a high-protein powder/ omega 3 oil and double distilled water from any kind of fish or animal ( protein)
RU2535038C2 (ru) 2009-06-25 2014-12-10 Криэлта Фармасьютикалз ЭлЭлСи Способы и наборы для прогнозирования риска инфузионных реакций и опосредованной антителами потери ответа при терапии пэгилированной уриказой с помощью мониторинга содержания мочевой кислоты в сыворотке крови
JP2015519361A (ja) 2012-05-31 2015-07-09 エイジェンシー・フォー・サイエンス，テクノロジー・アンド・リサーチ 正電荷有機添加剤での処理によるタンパク質製剤におけるタンパク質−不純物複合体及び凝集体のレベルを低下させるための方法
US9826757B2 (en) 2013-03-15 2017-11-28 Advance International Inc. Automated method and system for recovering protein powder meal, pure omega 3 oil and purified distilled water from animal tissue
WO2014192877A1 (ja) * 2013-05-29 2014-12-04 Jsr株式会社 洗浄用組成物、タンパク質精製方法、及びタンパク質
WO2015130223A1 (en) * 2014-02-27 2015-09-03 Agency For Science, Technology And Research Methods for reducing chromatin content in protein preparations by treatment with alkyl cations
CA2920789C (en) 2015-06-04 2021-05-18 Advance International, Inc. Improved methods and systems for recovering protein powder and natural omega-3 oil from animal tissue
US20200237881A1 (en) 2019-01-30 2020-07-30 Horizon Pharma Rheumatology Llc Reducing immunogenicity to pegloticase
EP3538135A4 (en) 2016-11-11 2020-07-29 Horizon Pharma Rheumatology LLC POLYTHERAPIES OF PREDNISONE AND URICASE MOLECULES AND THEIR USES
WO2019103106A1 (ja) * 2017-11-22 2019-05-31 学校法人東京薬科大学 凝集タンパク質の再生剤およびこれを用いた凝集タンパク質の再生方法
US12121566B2 (en) 2019-01-30 2024-10-22 Horizon Therapeutics Usa, Inc. Methods for treating gout
US12269875B2 (en) 2023-08-03 2025-04-08 Jeff R. Peterson Gout flare prevention methods using IL-1BETA blockers

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3797378A (en) * 1977-07-13 1980-01-17 Sandoz Ltd Paramyxovirus vaccine
AU7702787A (en) * 1986-07-28 1988-02-24 Allied Corporation Sulfonate benzotriazoles and their use in polyamide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4462940A (en) * 1982-09-23 1984-07-31 Cetus Corporation Process for the recovery of human β-interferon-like polypeptides
US4659568A (en) * 1985-02-27 1987-04-21 American Cyanamid Company Process for solubilization, purification and characterization of protein from insoluble protein aggregates or complexes and compositions of matter therefrom
US4656255A (en) * 1985-09-09 1987-04-07 International Minerals & Chemical Corp. Protein recovery

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3797378A (en) * 1977-07-13 1980-01-17 Sandoz Ltd Paramyxovirus vaccine
AU7702787A (en) * 1986-07-28 1988-02-24 Allied Corporation Sulfonate benzotriazoles and their use in polyamide

Also Published As

Publication number Publication date
EP0226448A2 (en) 1987-06-24
CA1281849C (en) 1991-03-19
MY101204A (en) 1991-08-17
EP0226448A3 (en) 1989-01-11
NZ218586A (en) 1989-07-27
JPS62223192A (ja) 1987-10-01
DK592186A (da) 1987-06-12
AU6687486A (en) 1987-06-18
NO864990D0 (no) 1986-12-10
DE3685562D1 (de) 1992-07-09
GR3004903T3 (OSRAM) 1993-04-28
NO864990L (no) 1987-06-12
DK592186D0 (da) 1986-12-10
EP0226448B1 (en) 1992-06-03
ES2032194T3 (es) 1993-01-16
ATE76878T1 (de) 1992-06-15
US4797474A (en) 1989-01-10
DK171331B1 (da) 1996-09-09
DE3685562T2 (de) 1992-12-24
JPH0660198B2 (ja) 1994-08-10
CN86108729A (zh) 1987-10-21

Similar Documents

Publication Publication Date Title
EP0226448B1 (en) Solubilisation of protein aggregates
CA1305284C (en) Method for the recovery of cellular proteins in active form
EP0279619B1 (en) Production of proteins in active forms
CA1219234A (en) Methods of purification and reactivation of precipitated heterologous proteins
CA1267497A (en) Protein recovery
Cardamone et al. Comparing the refolding and reoxidation of recombinant porcine growth hormone from a urea denatured state and from Escherichia coli inclusion bodies
US5008377A (en) Production of proteins in active forms
AU2010203836A1 (en) Separation method using single polymer phase systems
EP2958931B9 (en) Materials and methods for removing endotoxins from protein preparations
CA2699529A1 (en) Procedures for the separation of recombinant proteins in aqueous two-phase systems
CA2677023C (en) Method of purification of hydrophobic proteins
Arakawa et al. Isoform separation of proteins by mixed-mode chromatography
EP0295859B1 (en) Production of proteins in active forms
CN113461827A (zh) 高效分离纯化重组人凝血因子VIII Fc融合蛋白的方法
CA2372513A1 (en) Methods for protein purification using aqueous two-phase extraction
Liu et al. Derivatization of peptides and small proteins for improved identification and detection in capillary zone electrophoresis (CZE)
Tremaine et al. Limited proteolysis of southern bean mosaic virus by trypsin
CN100387614C (zh) 包涵体蛋白复性并同时纯化的方法
AU607988B2 (en) Production of proteins in active forms
US20090023902A1 (en) Method for the extraction of intracellular proteins from a fermentation broth
Lee et al. Purification of human antibodies by using liquid/liquid extraction

Legal Events

Date Code Title Description
PC Assignment registered

Owner name: NATINO NV

Free format text: FORMER OWNER WAS: SOUTHERN CROSS BIOTECH PTY LTD.

TH Corrigenda

Free format text: IN VOL 14, NO 7, PAGE(S) 1249-1250 UNDER THE HEADING ASSIGNMENTS REGISTERED THE NAME OF THE ASSIGNEE IN REGARD TO PATENT NUMBERS 597924, 599922, 612133, 617658, 618396, 647374 AND 664021 SHOULD READ NATINCO NV.